Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

EDWARD MARION TAVEL

Allopathic & Osteopathic Physicians Pain Medicine Pain Medicine

NPI
1508833468
CMS profile
295429
Location
CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$196.58

12 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $196.58 12

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $88.61 5
Virtus Pharmaceuticals LLC $46.29 3
AbbVie Inc. $18.72 1
Biogen, Inc. $15.89 1
Lilly USA, LLC $15.89 1
Forte Bio-Pharma LLC $11.18 1

Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

EDWARD MARION TAVEL

NPI 1508833468 · CMS profile ID 295429

Allopathic & Osteopathic Physicians / Pain Medicine / Pain Medicine

CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1508833468?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508833468?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508833468?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1508833468?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

12 matching records · $196.58 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 12 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–12 of 12.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $13.1712/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815914821 CMS
Lilly USA, LLC $15.8912/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819100055 CMS
Abbott Laboratories $13.5211/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815868943 CMS
Abbott Laboratories $17.6811/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815808813 CMS
Forte Bio-Pharma LLC $11.1810/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796756225 CMS
Virtus Pharmaceuticals LLC $13.8810/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844334287 CMS
AbbVie Inc. $18.7209/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796139829 CMS
Virtus Pharmaceuticals LLC $16.4009/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844334285 CMS
Virtus Pharmaceuticals LLC $16.0108/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844334283 CMS
Biogen, Inc. $15.8907/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827765265 CMS
Abbott Laboratories $21.6506/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815588883 CMS
Abbott Laboratories $22.5903/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818438139 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $298.90 19
PY2020 $211.18 10
PY2021 $196.58 12
PY2022 $145.16 4
PY2023 $152.15 3
PY2024 $225.10 4
PY2025 $1,202.06 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $76,931.00 6
PY2024 Principal investigator $5,493.00 5
PY2023 Principal investigator $36,326.87 10
PY2022 Principal investigator $206,426.48 18
PY2021 Principal investigator $480,791.84 39
PY2020 Principal investigator $359,176.17 70
PY2019 Principal investigator $217,263.17 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan Inc. $1,137.30 12/31/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 670122255
Principal investigator 1 Ironwood Pharmaceuticals, Inc $5,375.60 12/20/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400019
Principal investigator 1 Allergan Inc. $700.00 12/17/2019 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
A 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RELAMORELIN IN PATIENTS WITH DIABETIC GASTROPARESIS No dispute reported 06/30/2026 670113823
Principal investigator 1 Allergan Inc. $1,705.25 12/16/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 670111623
Principal investigator 1 Allergan Inc. $686.00 12/10/2019 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
A 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RELAMORELIN IN PATIENTS WITH DIABETIC GASTROPARESIS No dispute reported 06/30/2026 670107295
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $6,337.30 11/27/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee No dispute reported 06/30/2026 639750191
Principal investigator 1 Abbott Laboratories $11,141.00 11/06/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703425433
Principal investigator 1 Ironwood Pharmaceuticals, Inc $7,958.30 10/16/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400017
Principal investigator 1 Abbott Laboratories $26,539.50 07/31/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703417157
Principal investigator 1 Allergan Inc. $1,705.25 07/25/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 670060789
Principal investigator 1 Abbott Laboratories $1,224.85 07/11/2019 Non-covered Recipient Entity
Western Institutional Review Board
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703416929
Principal investigator 1 Ironwood Pharmaceuticals, Inc $1,190.10 07/03/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400015
Principal investigator 1 Flexion Therapeutics, Inc. $17,036.87 07/01/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis No dispute reported 06/30/2026 705979703
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $15,210.00 06/11/2019 Non-covered Recipient Entity
Clinical Trials Of South Carolina
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease No dispute reported 06/30/2026 639757643
Principal investigator 1 Ironwood Pharmaceuticals, Inc $30,117.20 05/17/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400013
Principal investigator 1 Abbott Laboratories $7,822.75 05/01/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703415051
Principal investigator 1 Ironwood Pharmaceuticals, Inc $46,498.20 04/05/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400011
Principal investigator 1 Ironwood Pharmaceuticals, Inc $5,375.60 02/13/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400009
Principal investigator 1 Abbott Laboratories $726.00 01/25/2019 Non-covered Recipient Entity
Western Institutional Review Board
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703411053
Principal investigator 1 Abbott Laboratories $21,622.25 01/23/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 703409997
Principal investigator 1 Ironwood Pharmaceuticals, Inc $73.00 01/11/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400005
Principal investigator 1 Ironwood Pharmaceuticals, Inc $5,375.60 01/04/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROL
C3718-302 No dispute reported 06/30/2026 705400007
Principal investigator 1 Allergan Inc. $1,705.25 01/03/2019 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RELAMORELIN IN PATIENTS WITH DIABETIC GASTROPARESIS No dispute reported 06/30/2026 670014693